scispace - formally typeset
G

Guy Berchem

Researcher at Centre Hospitalier de Luxembourg

Publications -  130
Citations -  11032

Guy Berchem is an academic researcher from Centre Hospitalier de Luxembourg. The author has contributed to research in topics: Autophagy & Tumor microenvironment. The author has an hindex of 43, co-authored 116 publications receiving 9463 citations. Previous affiliations of Guy Berchem include Institut Jules Bordet & Georgetown University.

Papers
More filters
Journal ArticleDOI

Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition)

Daniel J. Klionsky, +2522 more
- 21 Jan 2016 - 
TL;DR: In this paper, the authors present a set of guidelines for the selection and interpretation of methods for use by investigators who aim to examine macro-autophagy and related processes, as well as for reviewers who need to provide realistic and reasonable critiques of papers that are focused on these processes.
Journal ArticleDOI

Exosomes released by chronic lymphocytic leukemia cells induce the transition of stromal cells into cancer-associated fibroblasts

TL;DR: It is demonstrated that CLL-derived exosomes actively promote disease progression by modulating several functions of surrounding stromal cells that acquire features of cancer-associated fibroblasts, contributing to a tumor-supportive microenvironment.
Journal ArticleDOI

Cathepsin-D affects multiple tumor progression steps in vivo: proliferation, angiogenesis and apoptosis.

TL;DR: It is proposed that human cathepsin-D stimulates tumor growth by acting–directly or indirectly–as a mitogenic factor on both cancer and endothelial cells independently of its catalytic activity.
Journal ArticleDOI

Granzyme B degradation by autophagy decreases tumor cell susceptibility to natural killer-mediated lysis under hypoxia

TL;DR: It is demonstrated that hypoxia impairs breast cancer cell susceptibility to NK-mediated lysis in vitro via the activation of autophagy, which provides a cutting-edge advance in the understanding of the mechanism by which hyp oxia-induced autophagic impairs NK-mediation in vitro and paves the way for the formulation of more effective NK cell-based antitumor therapies.
Journal ArticleDOI

A secreted FGF-binding protein can serve as the angiogenic switch in human cancer.

TL;DR: Investigating whether the expression in tumors of a secreted fibroblast growth factor-binding protein (FGF-BP) that mobilizes and activates locally stored FGFs can serve as an angiogenic switch molecule found that the reduction of FGF- BP reduced the release of biologically active basic FGF (bFGF) from cells in culture.